230 related articles for article (PubMed ID: 2997300)
21. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
[TBL] [Abstract][Full Text] [Related]
22. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.
Nunn JD; Katz DR; Barker S; Fraher LJ; Hewison M; Hendy GN; O'Riordan JL
Immunology; 1986 Dec; 59(4):479-84. PubMed ID: 3026959
[TBL] [Abstract][Full Text] [Related]
23. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
[TBL] [Abstract][Full Text] [Related]
24. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM; Hirst MA; Feldman D
Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
Gamblin GT; Liberman UA; Eil C; Downs RW; DeGrange DA; Marx SJ
J Clin Invest; 1985 Mar; 75(3):954-60. PubMed ID: 3872316
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid.
Hirst MA; Hochman HI; Feldman D
J Clin Endocrinol Metab; 1985 Mar; 60(3):490-5. PubMed ID: 2982898
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect by 1,25-dihydroxyvitamin D3 on concanavalin A-stimulated proliferation of rat thymic lymphocytes.
Kojima A; Hato F; Kinoshita Y; Nishizawa Y; Morii H
Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):867-75. PubMed ID: 1477603
[TBL] [Abstract][Full Text] [Related]
28. 25-Hydroxyvitamin D-24-hydroxylase in phytohemagglutinin-stimulated lymphocytes: intermediate bioresponse to 1,25-dihydroxyvitamin D3 of cells from parents of patients with vitamin D-dependent rickets type II.
Takeda E; Yokota I; Ito M; Kobashi H; Saijo T; Kuroda Y
J Clin Endocrinol Metab; 1990 Apr; 70(4):1068-74. PubMed ID: 2156884
[TBL] [Abstract][Full Text] [Related]
29. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
30. High performance liquid chromatography analysis of 1,25-dihydroxyvitamin D3 receptor in malignant cells. Correlation of effects on cell proliferation and receptor concentration.
Thomas GA; Simpson RU
Cancer Biochem Biophys; 1986 Jul; 8(3):221-34. PubMed ID: 3017543
[TBL] [Abstract][Full Text] [Related]
31. 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes.
Reichel H; Koeffler HP; Tobler A; Norman AW
Proc Natl Acad Sci U S A; 1987 May; 84(10):3385-9. PubMed ID: 3033646
[TBL] [Abstract][Full Text] [Related]
32. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D and the hematolymphopoietic tissue: a 1994 update.
Manolagas SC; Yu XP; Girasole G; Bellido T
Semin Nephrol; 1994 Mar; 14(2):129-43. PubMed ID: 8177980
[TBL] [Abstract][Full Text] [Related]
34. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes.
Park K; Bae H; Heydemann A; Roberts AB; Dotto GP; Sporn MB; Kim SJ
Cancer Res; 1994 Dec; 54(23):6087-9. PubMed ID: 7954451
[TBL] [Abstract][Full Text] [Related]
35. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
Tanaka M; Muramatsu M; Higuchi S; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):3-13. PubMed ID: 7953192
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3.
Feldman D; Chen T; Cone C; Hirst M; Shani S; Benderli A; Hochberg Z
J Clin Endocrinol Metab; 1982 Nov; 55(5):1020-2. PubMed ID: 6288751
[TBL] [Abstract][Full Text] [Related]
37. Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia.
Adams JS; Gacad MA; Singer FR
J Clin Endocrinol Metab; 1984 Sep; 59(3):556-60. PubMed ID: 6547728
[TBL] [Abstract][Full Text] [Related]
38. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
[TBL] [Abstract][Full Text] [Related]
39. I alpha, 25-Dihydroxyvitamin D3 receptor in the X-linked hypophosphatemic mouse.
Seino Y; Sierra RI; Ichikawa M; Avioli LV
Endocrinology; 1982 Jul; 111(1):329-31. PubMed ID: 6282570
[TBL] [Abstract][Full Text] [Related]
40. [1,25-Dihydroxyvitamin D3 receptors in lymphocytes and T- and B-lymphocyte count in patients with glomerulonephritis].
Sergeev IN; Pletsityĭ KD; Rusnak FI; Spirichev VB
Vopr Med Khim; 1989; 35(6):117-21. PubMed ID: 2560867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
